Stanozolol 50 - Ice Pharmaceuticals

Winstrol, the commercial identity of Stanozolol, was introduced in 1962 following its synthesis by Winthrop Laboratories. Its pyrazole ring distinguished it chemically from most steroids, resulting in oral activity and a high anabolic-to-androgenic ratio. It was prescribed for clinical conditions including appetite loss, bone fragility, and recovery from prolonged illness. Even after FDA withdrawal, the drug retained pharmaceutical relevance overseas. Today, it remains in production in multiple countries and continues to be used in regulated veterinary practices and limited human settings.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 50 by Ice Pharmaceuticals, consult with your doctor or healthcare professional.